Twenty-five years of breast cancer risk models and their applications.
Mitchell H
MH
Gail
D000328:Adult; D000367:Age Factors; D000368:Aged; D018931:Antineoplastic Agents, Hormonal / Q000008:administration & dosage*; D000071060:Breast Density; D001943:Breast Neoplasms / Q000000981:diagnostic imaging / Q000453:epidemiology* / Q000401:mortality / Q000517:prevention & control*; D002423:Cause of Death; D003376:Counseling; D055088:Early Detection of Cancer / Q000379:methods / Q000592:standards / Q000639:trends; D005260:Female; D006801:Humans; D015994:Incidence; D042361:Mammary Glands, Human / Q000002:abnormalities; D008327:Mammography; D008403:Mass Screening / Q000379:methods / Q000592:standards / Q000639:trends; D008408:Mastectomy; D008875:Middle Aged; D015233:Models, Statistical; D011634:Public Health / Q000592:standards; D020849:Raloxifene Hydrochloride / Q000008:administration & dosage; D018570:Risk Assessment; D012307:Risk Factors; D018426:SEER Program; D020845:Selective Estrogen Receptor Modulators / Q000008:administration & dosage; D013629:Tamoxifen / Q000008:administration & dosage; D014481:United States / Q000453:epidemiology; D019564:Unnecessary Procedures; D044465:White People / Q000706:statistics & numerical data
D018931:Antineoplastic Agents, Hormonal; D020845:Selective Estrogen Receptor Modulators; D013629:Tamoxifen; D020849:Raloxifene Hydrochloride